Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| enteroendocrine cell | 6 studies | 48% ± 21% | |
| pancreatic A cell | 3 studies | 53% ± 14% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| pancreas | 3 studies | 24% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 91% | 225.71 | 224 / 245 | 94% | 42.48 | 473 / 502 |
| pancreas | 95% | 58.20 | 313 / 328 | 41% | 12.42 | 73 / 178 |
| adrenal gland | 41% | 80.69 | 105 / 258 | 63% | 110.91 | 145 / 230 |
| stomach | 79% | 44.18 | 285 / 359 | 9% | 2.49 | 25 / 286 |
| intestine | 65% | 53.57 | 632 / 966 | 7% | 4.57 | 37 / 527 |
| brain | 58% | 32.15 | 1539 / 2642 | 9% | 1.21 | 64 / 705 |
| uterus | 39% | 10.62 | 67 / 170 | 3% | 0.17 | 14 / 459 |
| ovary | 21% | 2.68 | 37 / 180 | 1% | 0.03 | 4 / 430 |
| esophagus | 7% | 2.40 | 105 / 1445 | 5% | 1.16 | 10 / 183 |
| adipose | 11% | 1.46 | 137 / 1204 | 0% | 0 | 0 / 0 |
| breast | 10% | 1.96 | 46 / 459 | 1% | 0.08 | 7 / 1118 |
| muscle | 10% | 3.16 | 83 / 803 | 0% | 0 | 0 / 0 |
| bladder | 10% | 1.14 | 2 / 21 | 1% | 0.07 | 3 / 504 |
| heart | 10% | 2.11 | 84 / 861 | 0% | 0 | 0 / 0 |
| thymus | 8% | 1.00 | 53 / 653 | 0% | 0 | 0 / 605 |
| lung | 3% | 0.41 | 20 / 578 | 3% | 0.45 | 40 / 1155 |
| kidney | 4% | 1.31 | 4 / 89 | 0% | 0.02 | 3 / 901 |
| blood vessel | 5% | 0.85 | 61 / 1335 | 0% | 0 | 0 / 0 |
| skin | 2% | 0.19 | 29 / 1809 | 3% | 0.28 | 12 / 472 |
| eye | 0% | 0 | 0 / 0 | 3% | 0.06 | 2 / 80 |
| liver | 1% | 0.15 | 3 / 226 | 1% | 0.03 | 4 / 406 |
| peripheral blood | 1% | 0.22 | 12 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0010628 | Biological process | positive regulation of gene expression |
| GO_0048665 | Biological process | neuron fate specification |
| GO_0042551 | Biological process | neuron maturation |
| GO_0042711 | Biological process | maternal behavior |
| GO_0030154 | Biological process | cell differentiation |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0016607 | Cellular component | nuclear speck |
| GO_0000785 | Cellular component | chromatin |
| GO_0005634 | Cellular component | nucleus |
| GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| Gene name | FEV |
| Protein name | Protein FEV (Fifth Ewing variant protein) (PC12 ETS domain-containing transcription factor 1) (PC12 ETS factor 1) (Pet-1) |
| Synonyms | PET1 |
| Description | FUNCTION: Functions as a transcriptional regulator. According to PubMed:12761502, it functions as a transcriptional repressor. Functions in the differentiation and the maintenance of the central serotonergic neurons. May play a role in cell growth. . |
| Accessions | ENST00000295727.2 Q99581 |